Prostate Cancer Clinical Trials in Long Beach, CA

Prostate Cancer Clinical Trials in Long Beach, CA

View the best 10 prostate cancer medical studies in Long Beach, California. Access promising new therapies by applying to a Long Beach-based Prostate Cancer clinical trial.

Top rated prostate cancer clinical trials in Long Beach, California

Here are the top 10 medical studies for prostate cancer in Long Beach, California

Image of Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers in Chandler, United States.

Talazoparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial looks at whether adding the drug talazoparib to the drug enzalutamide improves progression-free survival in men with metastatic castration-resistant prostate cancer.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Capivasertib +18 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Image of City of Hope Comprehensive Cancer Center in Duarte, United States.

Histrelin +11 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing two different intensities of hormone therapy and radiation therapy, comparing them to the current standard of care, in order to determine the best treatment plan for patients with high risk prostate cancer.
Image of Research Site in Lakewood, United States.

Capivasertib +1 More

AKT Inhibitor

Recruiting1 awardPhase 3
This trial will compare the efficacy of capivasertib+abiraterone+androgen deprivation therapy to placebo+abiraterone+androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC) whose tumours are PTEN-deficient. The primary endpoint is radiographic progression-free survival.
Image of Local Institution in Mobile, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing nivolumab with docetaxel in men with advanced prostate cancer who have not responded to other treatments.
Image of University of California at Davis in Davis, United States.

ONC-392 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug, ONC-392, as a possible treatment for advanced or metastatic solid tumors and non-small cell lung cancers. The trial will test different doses of the drug to see what is safe and what works best. The trial will also test ONC-392 in combination with another drug, pembrolizumab.
Image of Orange Coast Memorial Medical Center in Fountain Valley, United States.

CyberKnife

Proton Beam Therapy

Recruiting1 award
This trial will test the effectiveness of CyberKnife SABR in treating prostate cancer while also monitoring for side effects.
Image of Urological Associates of Southern Arizona, P.C . in Tucson, United States.

PF-06821497

BCL-2 Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug to treat adult patients with small cell lung cancer, castration resistant prostate cancer, or follicular lymphoma who have relapsed or are refractory to standard therapies.
Image of The University of California, Los Angeles in Encino, United States.

Etrumadenant

Adenosine Receptor Antagonist

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug, etrumadenant, to see if it is safe and effective at treating metastatic castrate resistant prostate cancer.
Image of Cedars Sinai in Los Angeles, United States.

177Lu-J591 +1 More

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial tests a new drug to see if it's effective against prostate cancer when used with ketoconazole and hydrocortisone.

Popular filter options for prostate-cancer long-beach trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

View More Prostate-cancer Long-beach Trials

See another 83 medical studies focused on prostate-cancer long-beach.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.